Literature DB >> 9934695

Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae.

O de Leeuw, B Peeters.   

Abstract

We have completely sequenced the genome of Newcastle disease virus (NDV) vaccine strain LaSota. The sequences of the 3'- and 5'-terminal ends of the RNA genome were determined by sequencing cDNA fragments generated by rapid amplification of cDNA ends. The entire genomic sequence, which was established by sequencing cDNA fragments generated by high-fidelity RT-PCR, consists of 15186 nt. Comparison of the 5'-terminal sequence of NDV LaSota with the 5'-terminal sequences of ten members of the Paramyxovirinae showed that NDV LaSota has an unusually long 5' untranscribed region. Comparison of the entire genomic sequences showed that NDV is only distantly related to the other members of the genus Rubulavirus, to which NDV has been assigned. In this paper we present data which suggest that NDV should not be classified in the genus Rubulavirus, but instead should be considered as a member of a new genus within the subfamily Paramyxovirinae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934695     DOI: 10.1099/0022-1317-80-1-131

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  92 in total

1.  Molecular characterization of avian paramyxovirus 1 isolates collected from cormorants in Canada from 1995 to 2000.

Authors:  H M Weingartl; J Riva; P Kumthekar
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae.

Authors:  L F Wang; M Yu; E Hansson; L I Pritchard; B Shiell; W P Michalski; B T Eaton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses.

Authors:  Madhuri Subbiah; Sa Xiao; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2008-06-20       Impact factor: 3.303

4.  Evaluation of the contributions of individual viral genes to newcastle disease virus virulence and pathogenesis.

Authors:  Anandan Paldurai; Shin-Hee Kim; Baibaswata Nayak; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

5.  Full-length genome sequence of avain paramyxovirus type 4 isolated from a mallard duck.

Authors:  Woo-Jin Jeon; Eun-Kyoung Lee; Jun-Hun Kwon; Kang-Seuk Choi
Journal:  Virus Genes       Date:  2008-09-03       Impact factor: 2.332

6.  Complete genome sequence and biological characterizations of a novel goose paramyxovirus-SF02 isolated in China.

Authors:  Jian Zou; Songhua Shan; Nengtao Yao; Zuxun Gong
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

7.  Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens.

Authors:  Silvina Chimeno Zoth; Evangelina Gómez; Juan Manuel Carballeda; Oscar Taboga; Elisa Carrillo; Analía Berinstein
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

8.  Genetic comparisons between lentogenic Newcastle disease virus isolated from waterfowl and velogenic variants.

Authors:  Ryota Tsunekuni; Hiroshi Ito; Koichi Otsuki; Hiroshi Kida; Toshihiro Ito
Journal:  Virus Genes       Date:  2009-12-12       Impact factor: 2.332

9.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.